Cystoid Macular Edema Clinical Trials

A listing of Cystoid Macular Edema medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
AG-73305 Single Ascending Dose Cohort Study in DME

This is a multi-centered, open-labeled, single ascending-dose-cohort study to evaluate 4 dosing cohorts of AG-73305 administered by intravitreal injection in patients with diabetic macular edema

  • 0 views
  • 04 Oct, 2022
  • 2 locations
Evaluation of Tonabersat for DME (AN)

This randomized clinical trial will evaluate the effect of tonabersat compared with placebo on central subfield thickness (CST) in eyes with center-involved diabetic macular edema (CI-DME) and

  • 0 views
  • 29 Aug, 2023
  • 12 locations
  • 0 views
  • 12 Apr, 2023
  • 1 location
Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX) (LOADEX)

Nowadays, steroids and anti-VEGF are the first line treatment for diabetic macular edema. Ozurdex is the most frequently used steroid and has label for both first and second line treatment

  • 0 views
  • 10 Apr, 2023
  • 16 locations
Mean Visual Acuity Changes Following Five Injections of Aflibercept

Diabetic Macular Edema is a serious ocular consequence of poorly controlled diabetes. Even though significant research has been done to clarify the pathogenesis of DME, a clear causal pathway of

eylea
Accepts healthy volunteers
diabetes
aflibercept injection
aflibercept
  • 9 views
  • 10 Apr, 2023
  • 1 location
A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening (Protocol AF)

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 4 years of follow-up in eyes with mild to moderately severe non-proliferative DR (NPDR) and no CI-DME at baseline. In addition to evaluating efficacy, this study aims to evaluate the …

microaneurysms
pupil dilation
insulin
severe nonproliferative diabetic retinopathy
diabetes
  • 35 views
  • 27 Oct, 2022
  • 48 locations
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease (OCTA-RVD)

This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care …

retinopathy
diabetic retinopathy
thyroid disease
eye disorder
eye disease
  • 704 views
  • 23 Aug, 2023
  • 1 location
Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits

Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform …

visual loss
glaucoma
eye disease
Accepts healthy volunteers
diabetes
  • 0 views
  • 07 Apr, 2023
  • 1 location
Clinical Applications of Advanced Ophthalmic Imaging

The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls. There are two phases in this study. The first phase is an observational phase …

mild cognitive impairment
disease or disorder
multiple sclerosis
dry eyes
alzheimer's disease
  • 630 views
  • 18 Sep, 2023
  • 1 location
4D-150 in Patients With Diabetic Macular Edema

Phase 2 randomized, active-controlled, double-masked, dose-ranging trial in adults with Diabetic Macular Edema (DME).

  • 0 views
  • 03 Sep, 2023
  • 7 locations